| Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs JC Rose, NA Popp, CD Richardson, JJ Stephany, J Mathieu, CT Wei, ... Nature communications 11 (1), 2697, 2020 | 64 | 2020 |
| High efficiency CRISPR/Cas9-mediated gene editing in primary human T-cells using mutant adenoviral E4orf6/E1b55k “helper” proteins KS Gwiazda, AE Grier, J Sahni, SM Burleigh, U Martin, JG Yang, NA Popp, ... Molecular therapy 24 (9), 1570-1580, 2016 | 41 | 2016 |
| The role of sex in uveitis and ocular inflammation IYL Yeung, NA Popp, CC Chan International ophthalmology clinics 55 (3), 111-131, 2015 | 41 | 2015 |
| Animal models of age-related macular degeneration and their translatability into the clinic S Chen, NA Popp, CC Chan Expert review of ophthalmology 9 (4), 285-295, 2014 | 24 | 2014 |
| Functional single nucleotide polymorphism in IL−17A 3′ untranslated region is targeted by miR‐4480 in vitro and may be associated with age‐related macular … NA Popp, D Yu, B Green, EY Chew, B Ning, CC Chan, J Tuo Environmental and molecular mutagenesis 57 (1), 58-64, 2016 | 17 | 2016 |
| Responses of multipotent retinal stem cells to IL-1β, IL-18, or IL-17 S Chen, D Shen, NA Popp, AJ Ogilvy, J Tuo, M Abu-Asab, T Xie, CC Chan Journal of Ophthalmology 2015, 2015 | 14 | 2015 |
| Evaluating potential therapies in a mouse model of focal retinal degeneration with age-related macular degeneration (AMD)-like lesions N Popp, XK Chu, D Shen, J Tuo, CC Chan Journal of clinical & experimental ophthalmology 4 (5), 1000296, 2013 | 12 | 2013 |
| A chemically controlled Cas9 switch enables temporal modulation of diverse effectors CT Wei, NA Popp, O Peleg, RL Powell, E Borenstein, DJ Maly, DM Fowler Nature chemical biology 19 (8), 981-991, 2023 | 8 | 2023 |
| No Sex Differences in the Frequencies of Common Single Nucleotide Polymorphisms Associated with Age-Related Macular Degeneration NA Popp, E Agrón, GS Hageman, J Tuo, EY Chew, CC Chan Current eye research 42 (3), 470-475, 2017 | 2 | 2017 |
| Multiplex, multimodal mapping of variant effects in secreted proteins NA Popp, RL Powell, MK Wheelock, BD Zapp, KJ Holmes, KM Sheldon, ... bioRxiv, 2024.04. 01.587474, 2024 | | 2024 |
| Functional Assessment of VWD Type 2N Variants Using Mammalian Cell Displayed Surface-Tethered Von Willebrand Factor KW Lannert, SN Fletcher, NA Popp, PA Christopherson, DJ Hampshire, ... Blood 142, 2604, 2023 | | 2023 |
| Building multiplexed genomic tools for editing and interpreting human variation NA Popp University of Washington, 2023 | | 2023 |
| Comprehensive Characterization of Missense Variation in Coagulation Factor IX Reveals Features Necessary for Secretion and γ-Carboxylation NA Popp, RL Powell, B Zapp, K Lannert, JM Johnsen, DM Fowler Blood 140 (Supplement 1), 5582-5583, 2022 | | 2022 |
| Catalytically inactive truncated guide rna compositions and related methods for suppression of crispr/cas off-target editing JC Rose, D James, D Fowler, N Popp US Patent App. 17/144,944, 2021 | | 2021 |
Chi-Chao ChanNational Eye Institute, National Institutes of HealthVerified email at nei.nih.gov
